Correction to: Refractory anti‑NMDAR encephalitis successfully treated with bortezomib and associated movements disorders controlled with tramadol: a case report with literature review

J Neurol. 2021 Feb;268(2):741-742. doi: 10.1007/s00415-020-10370-z.

Serena Marita Lazzarin^{1

2}, Marco Vabanesi^{1

2}, Giordano Cecchetti^{1

2}, Raffaella Fazio¹, Giovanna Franca Fanelli², Maria Antonietta Volonté¹, Angela Genchi¹, Antonino Giordano¹, Vittorio Martinelli¹, Sergio Colombo³, Paolo Beccaria³, Milena Mucci³, Jacopo Peccatori⁴, Massimo Filippi^{5

6

7

8}, Fabio Minicucci²

¹ Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
² Neurophysiology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
³ General Intensive Care Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
⁴ Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
⁵ Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy. filippi.massimo@hsr.it.
⁶ Neurophysiology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy. filippi.massimo@hsr.it.
⁷ Neuroimaging Research Unit, Institute of Experimental Neurology, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Via Olgettina, 60, 20132, Milan, Italy. filippi.massimo@hsr.it.
⁸ Vita-Salute San Raffaele University, Milan, Italy. filippi.massimo@hsr.it.

No abstract available

Publication types